Ramaswamy Vivek

SEC Form 4 insider trading activity

Ramaswamy Vivek has filed 4 SEC Form 4 filings (16 transaction rows) across 2 companies, including ROIV, ASST, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Dec 15, 2025.

On the most recent filing, Ramaswamy Vivek is listed as 10% Owner at Roivant Sciences Ltd. Inside the rolling window, Ramaswamy Vivek reported 1 open-market purchase totaling $1.3M in ASST and 6 open-market sales totaling $105.9M in ROIV. The largest disclosed transaction in the window is a sale of 1,975,858 ROIV shares on Dec 12, 2025, worth $43.4M.

Companies traded

Other insiders at ROIV

Insider Buying

$1.3M

reported purchases (SEC code P)

Insider Selling

$105.9M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ROIVSale$16.8MDec 15SEC ↗
ROIVSale$43.4MDec 15SEC ↗
ROIVSale$7.8MDec 15SEC ↗
ROIVSale$6.0MNov 17SEC ↗
ROIVSale$20.9MNov 17SEC ↗
ROIVSale$11.1MNov 17SEC ↗
ASSTPurchase$1.3MNov 7SEC ↗
Showing 1–7 of 7
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 5, 2025ROIVSale$5.0M
Sep 4, 2025ROIVSale$2.5M
Sep 3, 2025ROIVSale$14.9M
Showing 1–3 of 3
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Ramaswamy Vivek made?

Ramaswamy Vivek has filed 4 SEC Form 4 filings (16 transaction rows) across 2 companies, including ROIV, ASST since 2025.

Which companies does Ramaswamy Vivek trade?

Ramaswamy Vivek has filed SEC Form 4 disclosures for 2 companies, including ROIV, ASST.

When was Ramaswamy Vivek's most recent SEC Form 4 filing?

Ramaswamy Vivek's most recent SEC Form 4 filing on Tracefour is dated Dec 15, 2025.

What is Ramaswamy Vivek's total buy and sell value in the current window?

Inside the rolling retention window, Ramaswamy Vivek bought $1.3M and sold $105.9M based on SEC Form 4 filings.

What was Ramaswamy Vivek's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,975,858 ROIV shares on 2025-12-12, worth $43.4M, per SEC Form 4 filings.